Cargando…

Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options

Neuromas form as a result of disorganized sensory axonal regeneration following nerve injury. Painful neuromas lead to poor quality of life for patients and place a burden on healthcare systems. Modern surgical interventions for neuromas entail guided regeneration of sensory nerve fibers into muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamoun, Feras, Shamoun, Valentina, Akhavan, Arya, Tuffaha, Sami H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295905/
https://www.ncbi.nlm.nih.gov/pubmed/35866159
http://dx.doi.org/10.3389/fnmol.2022.859221
_version_ 1784750152469184512
author Shamoun, Feras
Shamoun, Valentina
Akhavan, Arya
Tuffaha, Sami H.
author_facet Shamoun, Feras
Shamoun, Valentina
Akhavan, Arya
Tuffaha, Sami H.
author_sort Shamoun, Feras
collection PubMed
description Neuromas form as a result of disorganized sensory axonal regeneration following nerve injury. Painful neuromas lead to poor quality of life for patients and place a burden on healthcare systems. Modern surgical interventions for neuromas entail guided regeneration of sensory nerve fibers into muscle tissue leading to muscle innervation and neuroma treatment or prevention. However, it is unclear how innervating denervated muscle targets prevents painful neuroma formation, as little is known about the fate of sensory fibers, and more specifically pain fiber, as they regenerate into muscle. Golgi tendon organs and muscle spindles have been proposed as possible receptor targets for the regenerating sensory fibers; however, these receptors are not typically innervated by pain fibers, as these free nerve endings do not synapse on receptors. The mechanisms by which pain fibers are signaled to cease regeneration therefore remain unknown. In this article, we review the physiology underlying nerve regeneration, the guiding molecular signals, and the target receptor specificity of regenerating sensory axons as it pertains to the development and prevention of painful neuroma formation while highlighting gaps in literature. We discuss management options for painful neuromas and the current supporting evidence for the various interventions.
format Online
Article
Text
id pubmed-9295905
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92959052022-07-20 Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options Shamoun, Feras Shamoun, Valentina Akhavan, Arya Tuffaha, Sami H. Front Mol Neurosci Neuroscience Neuromas form as a result of disorganized sensory axonal regeneration following nerve injury. Painful neuromas lead to poor quality of life for patients and place a burden on healthcare systems. Modern surgical interventions for neuromas entail guided regeneration of sensory nerve fibers into muscle tissue leading to muscle innervation and neuroma treatment or prevention. However, it is unclear how innervating denervated muscle targets prevents painful neuroma formation, as little is known about the fate of sensory fibers, and more specifically pain fiber, as they regenerate into muscle. Golgi tendon organs and muscle spindles have been proposed as possible receptor targets for the regenerating sensory fibers; however, these receptors are not typically innervated by pain fibers, as these free nerve endings do not synapse on receptors. The mechanisms by which pain fibers are signaled to cease regeneration therefore remain unknown. In this article, we review the physiology underlying nerve regeneration, the guiding molecular signals, and the target receptor specificity of regenerating sensory axons as it pertains to the development and prevention of painful neuroma formation while highlighting gaps in literature. We discuss management options for painful neuromas and the current supporting evidence for the various interventions. Frontiers Media S.A. 2022-07-05 /pmc/articles/PMC9295905/ /pubmed/35866159 http://dx.doi.org/10.3389/fnmol.2022.859221 Text en Copyright © 2022 Shamoun, Shamoun, Akhavan and Tuffaha. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Shamoun, Feras
Shamoun, Valentina
Akhavan, Arya
Tuffaha, Sami H.
Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options
title Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options
title_full Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options
title_fullStr Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options
title_full_unstemmed Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options
title_short Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options
title_sort target receptors of regenerating nerves: neuroma formation and current treatment options
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295905/
https://www.ncbi.nlm.nih.gov/pubmed/35866159
http://dx.doi.org/10.3389/fnmol.2022.859221
work_keys_str_mv AT shamounferas targetreceptorsofregeneratingnervesneuromaformationandcurrenttreatmentoptions
AT shamounvalentina targetreceptorsofregeneratingnervesneuromaformationandcurrenttreatmentoptions
AT akhavanarya targetreceptorsofregeneratingnervesneuromaformationandcurrenttreatmentoptions
AT tuffahasamih targetreceptorsofregeneratingnervesneuromaformationandcurrenttreatmentoptions